AFRM vs PPCB · P/E 590, rev $3.22B vs P/E 0.0, $3.9M cap
Affirm Holdings Inc (AFRM) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
PPCB does not have a complete income-statement cache yet.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the AFRM and PPCB stock pages for the full models.
Not investment advice.